GANX

Gain TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

GANX vs peer average

87/100

GANX vs. peer average (B vs. D)

Grade spread

B 1 · D 3 · F 5

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

FATE is the first available peer comparator.

Loose clinical-stage biotech comparator for binary development milestones and capital-markets dependence; useful for trading-context only, not product or indication match.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerFATEFate Therapeutics

GANX

Gain Therapeutics

FATE

Fate Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs FATE

GANX / FATE

Grade Position

Above peers

GANX vs. peer average (B vs. D)

87/100

Momentum

GANX

Value

GANX

Sentiment

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs GANX

FATE

20/100

COYA

20/100

EXOZ

eXoZymes Inc Common

N/A

ACET

Adicet Bio Inc Common

20/100

FBIO

Fortress Biotech Inc Common

40/100

FATE is the first peer returned for this comparison set.